Recombinant Anti-MSLN x Anti-CD47 Bispecific Antibody (Common heavy chain) (BsIgG) (KN-1022-LN2)

Recombinant Anti-MSLN x Anti-CD47 Bispecific Antibody (BsIgG) is designed to be expressed as three chains, one common heavy chain, one kappa light chain and one lambda light chain. It has the general size and structure of a conventional IgG. This BsAb can retarget macrophages to tumor cells. It is designed for the research of solid tumors therapy.

Datasheet INQUIRY

Specifications

Targets

MSLN & CD47

Type

BsIgG

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Solid tumors

Targets

Target 1

MSLN

Gene ID

10232

UniProt ID

Q13421

Alternative Names

MSLN; MPF; SMRP; mesothelin

Target 2

CD47

Gene ID

961

UniProt ID

Q08722

Alternative Names

CD47; CD47 molecule; IAP; OA3; MER6; leukocyte surface antigen CD47; CD47 glycoprotein; Rh-related antigen; integrin associated protein; integrin-associated protein; integrin-associated signal transducer; antigenic surface determinant protein OA3; antigen identified by monoclonal antibody 1D8; CD47 antigen (Rh-related antigen, integrin-associated signal transducer)

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

See other bsAb targets related to "CD47"

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-MSLN x Anti-CD47 Bispecific Antibody (Common heavy chain) (BsIgG) (KN-1022-LN2). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-MSLN x Anti-CD47 Bispecific Antibody (Common heavy chain) (BsIgG) (CAT#: KN-1022-LN2)

Specifications

Targets

Customer Reviews and Q&As